These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25668439)

  • 1. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.
    Wan H; Yang H; Shore DA; Garten RJ; Couzens L; Gao J; Jiang L; Carney PJ; Villanueva J; Stevens J; Eichelberger MC
    Nat Commun; 2015 Feb; 6():6114. PubMed ID: 25668439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
    Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
    J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
    Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
    Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Koga M; Adachi E; Kikuchi T; Wang IH; Yamada S; Kawaoka Y
    Nat Microbiol; 2019 Jun; 4(6):1024-1034. PubMed ID: 30886361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal anti-neuraminidase antibody inhibiting all influenza A subtypes.
    Doyle TM; Hashem AM; Li C; Van Domselaar G; Larocque L; Wang J; Smith D; Cyr T; Farnsworth A; He R; Hurt AC; Brown EG; Li X
    Antiviral Res; 2013 Nov; 100(2):567-74. PubMed ID: 24091204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
    Wilson JR; Guo Z; Reber A; Kamal RP; Music N; Gansebom S; Bai Y; Levine M; Carney P; Tzeng WP; Stevens J; York IA
    Antiviral Res; 2016 Nov; 135():48-55. PubMed ID: 27713074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
    Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
    J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.
    Job ER; Ysenbaert T; Smet A; Van Hecke A; Meuris L; Kleanthous H; Saelens X; Vogel TU
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus.
    Jiang H; Peng W; Qi J; Chai Y; Song H; Bi Y; Rijal P; Wang H; Oladejo BO; Liu J; Shi Y; Gao GF; Townsend AR; Wu Y
    mBio; 2020 Oct; 11(5):. PubMed ID: 33024040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].
    Masalova OV; Chichev EV; Fediakina IT; Mukasheva EA; Klimova RR; Shchelkanov MIu; Burtseva EI; Ivanova VT; Kushch AA; L'vov DK
    Vopr Virusol; 2014; 59(3):34-40. PubMed ID: 25335417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
    PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
    Hansen L; McMahon M; Turner HL; Zhu X; Turner JS; Ozorowski G; Stadlbauer D; Vahokoski J; Schmitz AJ; Rizk AA; Alsoussi WB; Strohmeier S; Yu W; Choreño-Parra JA; Jiménez-Alvarez L; Cruz-Lagunas A; Zúñiga J; Mudd PA; Cox RJ; Wilson IA; Ward AB; Ellebedy AH; Krammer F
    Immunity; 2023 Aug; 56(8):1927-1938.e8. PubMed ID: 37506693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
    Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
    Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.
    Wang W; Sun X; Li Y; Su J; Ling Z; Zhang T; Wang F; Zhang H; Chen H; Ding J; Sun B
    Nat Commun; 2016 Dec; 7():13577. PubMed ID: 27910950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness.
    Tu V; Abed Y; Barbeau X; Carbonneau J; Fage C; Lagüe P; Boivin G
    Antiviral Res; 2017 Jan; 137():6-13. PubMed ID: 27838351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
    Prevato M; Ferlenghi I; Bonci A; Uematsu Y; Anselmi G; Giusti F; Bertholet S; Legay F; Telford JL; Settembre EC; Maione D; Cozzi R
    PLoS One; 2015; 10(8):e0135474. PubMed ID: 26280677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.